Literature DB >> 9150707

Biosynthesis, processing and sorting of neutrophil proteins: insight into neutrophil granule development.

U Gullberg1, E Andersson, D Garwicz, A Lindmark, I Olsson.   

Abstract

Neutrophil granulocytes are specialized phagocytic cells that carry a collection of granules for regulated secretion, each with distinct constituents. The granules can be classified as azurophil (primary), developed first, followed in time by specific (secondary) granules gelatinase granules, and secretory vesicles. Stage- and tissue-specific transcription factors govern the successive expression of genes for granule proteins to allow storage of the gene products in these organelle categories whose packaging is separated in time. Many of the granule proteins, in particular those of the heterogeneous lysosome-like azurophil granules, are subject to extensive post-translational proteolytic processing into mature proteins, most commonly as a post-sorting event. A selective aggregation of proteins destined for storage in granules, as discussed in this review, would facilitate their retention and eliminate a need for distinct sorting motifs on each granule protein. Aggregation of granule proteins, that are often cationic, would be assisted by the anionic serglycin proteoglycans present in neutrophils. The antibacterial granule proteins can serve as models for antibiotics and some of them possess a potentially useful therapeutic ability to bind and neutralize endotoxin. Because aberrant expression of transcription factors regulating the synthesis of granule proteins is often found in leukemia, the clarification of mechanisms regulating the timed expression of granule proteins will shed light on the maturation block in myeloid leukemias.

Entities:  

Mesh:

Year:  1997        PMID: 9150707     DOI: 10.1111/j.1600-0609.1997.tb00940.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  32 in total

1.  The proper study of mankind.

Authors:  W M Nauseef
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

Review 2.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 3.  The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease.

Authors:  Hendrik Schultz; Jerrold P Weiss
Journal:  Clin Chim Acta       Date:  2007-07-13       Impact factor: 3.786

Review 4.  Older but Not Wiser: the Age-Driven Changes in Neutrophil Responses during Pulmonary Infections.

Authors:  Shaunna R Simmons; Manmeet Bhalla; Sydney E Herring; Essi Y I Tchalla; Elsa N Bou Ghanem
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

Review 5.  Gonococcal Defenses against Antimicrobial Activities of Neutrophils.

Authors:  Allison Palmer; Alison K Criss
Journal:  Trends Microbiol       Date:  2018-08-13       Impact factor: 17.079

Review 6.  The Ontogeny of a Neutrophil: Mechanisms of Granulopoiesis and Homeostasis.

Authors:  Shelley M Lawrence; Ross Corriden; Victor Nizet
Journal:  Microbiol Mol Biol Rev       Date:  2018-02-07       Impact factor: 11.056

7.  Arginine to cysteine mutation (R499C) found in a Japanese patient with complete myeloperoxidase deficiency.

Authors:  Amanda S Persad; Yosuke Kameoka; Shuji Kanda; Yoshiyuki Niho; Kazuo Suzuki
Journal:  Gene Expr       Date:  2006

8.  Subversion of a lysosomal pathway regulating neutrophil apoptosis by a major bacterial toxin, pyocyanin.

Authors:  Lynne R Prince; Stephen M Bianchi; Kathryn M Vaughan; Martin A Bewley; Helen M Marriott; Sarah R Walmsley; Graham W Taylor; David J Buttle; Ian Sabroe; David H Dockrell; Moira K B Whyte
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

9.  Vitamin D(3) induces expression of human cathelicidin antimicrobial peptide 18 in newborns.

Authors:  Yuka Misawa; Atsushi Baba; Susumu Ito; Miyuki Tanaka; Masaaki Shiohara
Journal:  Int J Hematol       Date:  2009-11-28       Impact factor: 2.490

10.  Expression of bactericidal/permeability-increasing protein requires C/EBP epsilon.

Authors:  Miyuki Tanaka; Adrian F Gombart; H Phillip Koeffler; Masaaki Shiohara
Journal:  Int J Hematol       Date:  2007-05       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.